The People's Pharmacy · Joe and Terry Graedon

Show 1432: Lead, Lies and Lasting Harm: The Chemical Roots of Chronic Disease

May 29, 2025·1 hr·5 clips
Lead exposure doubles coronary heart disease risk, matching smoking but affecting everyone, not just smokers.
The episode begins with Joe and Terry Graydon welcoming listeners to The People's Pharmacy. It opens with the reminder that gasoline once contained lead and that lead was also added to paint. The hosts frame the topic as a public health question. Their guest is Dr. Bruce Lanphier, a professor of health sciences at Simon Fraser University. He has been studying lead and fluoride for years. The conversation centers on how toxic chemicals can shape long-term health in an industrialized world. Lanphier argues that many chronic diseases are, in a real sense, man-made because they grow out of industrial life. The episode asks what people should know about toxic chemicals and how industry has often hidden their long-term health effects. Before the main interview settles in, the show includes health headlines. One item covers a new COVID-19 strain surging in China. The variant is called NB.1.8.1. The CDC airport screening program has detected cases entering the United States starting in late March and early April. The headlines note that the variant is more transmissible than previous strains, including Omicron. The discussion then returns to lead and disease. Lanphier describes how a scientific meeting left him surprised that lead was not treated as a risk factor for coronary heart disease or heart attacks, despite the evidence. He says the evidence convinced him that lead should be taken seriously. He explains that failing to recognize the risk means failing to address it. The interview turns to the idea of global burden of disease. Lanphier describes the need to estimate what fraction of coronary heart disease or heart attacks may be attributable to lead exposure. He lays out the core pieces of the problem. A strong hypothesis is needed. Exposure must be measured. The outcome must be defined. A cohort must be available for follow-up. He says NHANES provided that cohort. NHANES is presented as a long-running surveillance program that has been going on since the 1970s. It collects baseline information on all varieties of things, including blood pressure and lead. Participants can then be followed over time. Lanphier says this kind of data is useful because it allows researchers to connect exposure to later death and disease. The conversation keeps circling back to the same central concern. Lead exposure happened on a large scale. The consequences may have been recognized too late. The interview treats that delay as part of the story, not just a research problem. The episode closes with the show's usual fundraising and sponsorship material after the editorial conversation ends.

As heard by us

A careful look at lead exposure, chronic disease, and the cost of looking away.

Lead sits at the center of the episode, and that gives the discussion real weight as a public health story about harm that lasts. It moves from gasoline and paint to the wider problem of long-term chemical exposure going unrecognized, then returns to the link between lead and…

Read the full review in PlayNext →

Why you'd press play

You want the case for lead as a possible driver of chronic disease.

Read the full recommendation in PlayNext →
Listen to the show on